2022 Psychedelic Healing Summit
Program & Replays
Integration As Medicine: Ketamine and Beyond
Integration is the medicine — and as Dr. Hannah McLane and Dr. Elias Dakwar explore in this conversation, integration of the experiences we have in ketamine- and other medically-assisted therapies can deeply transform both the individual and their community.
Elias Dakwar, MD
Dr. Elias Dakwar researches novel treatments for addictions with the support of several grants from NIDA and NIAAA. A special focus of his research has been evaluating sub-anesthetic ketamine infusions for cocaine use disorders in both laboratory and clinical settings, as well as investigating ketamine infusions as an adjunct to mindfulness-based treatment, motivational interviewing, and other behavioral frameworks for alcohol, cannabis, and opioid use disorders. He has a more general interest in the impact of non-ordinary experiences, and of the interventions that might occasion them, in psychiatric treatment.
Hannah McLane, MD, MA, MPH
Hannah McLane, MD, MA, MPH, is a physician, psychotherapist, and entrepreneur. She is the founder of SoundMind, an initiative dedicated to bringing equity, ethics, and innovation to the psychedelic ecosystem. She is the medical director of Soundmind Center, a flagship psychedelic therapy center in Philadelphia, PA. She is originally from New Hampshire, a proud dyslexic, and mother of one rambunctious toddler.
Dr. McLane holds degrees from McGill University (BA, International Development Studies), Temple University (MA, Communication Sciences), Brown University (MD, Doctor of Medicine), and Harvard School of Public Health (MPH, Global health and Bioethics). Her residency experiences include neurology and occupational and environmental medicine (University of Pennsylvania). Her post-residency training includes postdoc fellowship in patient safety (VA Medical Center, Philadelphia), psychoanalytic training (PCOP), and MDMA-assisted-psychotherapy training (MAPS).